Clinical trial

Safety and Efficiency of γδ T Cell Against Lung Cancer

NCT03183232

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-06-15

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2017-06-15Date precision: day

Registry last updated2020-07-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Interventions

Cryosurgery or IRE surgeryPROCEDURE

γδ T cellBIOLOGICAL

γδ T cells/ A Cryosurgery or IREOTHER

Sponsors & collaborators

Fuda Cancer Hospital, Guangzhoulead sponsor

Jinan University Guangzhoucollaborator

Mapped research locations

GuangzhouGuangdong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03183232 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.